Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Riccardo Farinella

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4272-1696; OpenAlex author ID A5057957242. Sources: OpenAlex.

Their work

Papers
16 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2023: 4 papers · 2024: 4 papers · 2025: 8 papers

Papers 16

  1. Author's Reply: Comment on "Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarci… Co-author DOI 10.1016/j.dld.2024.12.025↗
  2. Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Co-author DOI 10.1016/j.semcancer.2025.01.003↗
  3. The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer. First author DOI 10.1016/j.semcancer.2025.03.002↗
  4. From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Co-author DOI 10.1016/j.semcancer.2025.03.004↗
  5. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  6. Therapeutic pancreatic cancer biomarkers and pharmacogenetics. Co-author DOI 10.1016/j.semcancer.2025.08.002↗
  7. Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Co-author DOI 10.1093/mutage/gead034↗
  8. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  9. Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.dld.2023.10.015↗
  10. Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. First author DOI 10.1038/s41598-024-77431-5↗
  11. Publisher Correction: Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomi… First author DOI 10.1038/s41598-024-83618-7↗
  12. Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study. Co-author DOI 10.1210/jendso/bvae017↗
  13. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. First author DOI 10.1002/ijc.34383↗
  14. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  15. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarc… Co-author DOI 10.1093/carcin/bgad056↗
  16. Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. Co-author DOI 10.3389/fonc.2023.1172606↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniele Campa · 13 shared papers, 2023–2025 · strength 2.71
  2. Cosmeri Rizzato · 7 shared papers, 2023–2025 · strength 1.53
  3. Manuel Gentiluomo · 7 shared papers, 2023–2025 · strength 1.42
  4. Giulia Peduzzi · 6 shared papers, 2024–2025 · strength 1.36
  5. Federico Canzian · 7 shared papers, 2023–2025 · strength 1.31
  6. Neil Daniel · 4 shared papers, 2024–2025 · strength 0.86
  7. David J. Hughes · 4 shared papers, 2024–2025 · strength 0.86
  8. Chiara Corradi · 3 shared papers, 2023–2025 · strength 0.63
  9. Pavel Souček · 3 shared papers, 2023–2025 · strength 0.62
  10. Gabriele Capurso · 3 shared papers, 2023–2024 · strength 0.46
  11. Marco Calderisi · 2 shared papers, 2024–2025 · strength 0.42
  12. Ștefania Bunduc · 2 shared papers, 2023–2025 · strength 0.35
  13. Beatrice Mohelníková-Duchoňová · 2 shared papers, 2023–2025 · strength 0.35
  14. Pavel Vodička · 2 shared papers, 2023–2025 · strength 0.31
  15. Lívia Archibugi · 2 shared papers, 2023–2025 · strength 0.31
  16. Stefano Landi · 2 shared papers, 2023–2025 · strength 0.31
  17. Luca Morelli · 2 shared papers, 2023 · strength 0.26
  18. Michal Kroupa · 1 shared paper, 2025 · strength 0.24
  19. Viktor Hlaváč · 1 shared paper, 2025 · strength 0.24
  20. Aleš Langer · 1 shared paper, 2025 · strength 0.24
  21. Roger Laughlin Milne · 1 shared paper, 2024 · strength 0.23
  22. Sabrina Gloria Giulia Testoni · 1 shared paper, 2025 · strength 0.22
  23. Matteo Tacelli · 1 shared paper, 2025 · strength 0.22
  24. Ricardo Blázquez‐Encinas · 1 shared paper, 2025 · strength 0.22
  25. Eithne Costello · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.